Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Deenah Ragnauth

Nurse Practitioner, Psychiatric/Mental Health Kissimmee, FL Nurse Practitioner

NPI 1033446018 CMS profile 11096320

206 Park Place Blvd, Kissimmee, FL 34741

Open in the dashboard

General payments

$8,841

434 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Deenah Ragnauth of Kissimmee, FL is reported in the CMS Open Payments database as having received $8,841 across 434 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Nurse Practitioner, Psychiatric/Mental Health profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $1,499 62
2024 General $1,642 73
2023 General $2,287 108
2022 General $1,528 83
2021 General $1,885 108

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Deenah Ragnauth
  • Nurse Practitioner, Psychiatric/Mental Health median
  • Middle half of Nurse Practitioner, Psychiatric/Mental Health
  • National median

In program year 2025, general payments to Deenah Ragnauth were reported at $1,499. Among 26,152 Nurse Practitioner, Psychiatric/Mental Health profiles paid that year, the median was $258 and the middle half received between $93 and $764.

Show as a table
Year Deenah Ragnauth Nurse Practitioner, Psychiatric/Mental Health median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $1,885 $166 $54–$482 $132
2022 $1,528 $195 $66–$559 $149
2023 $2,287 $233 $82–$673 $160
2024 $1,642 $236 $84–$688 $164
2025 $1,499 $258 $93–$764 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AbbVie, Inc. $2,132 100 payments
  2. Corium, Inc. $1,566 61 payments
  3. Neos Therapeutics, LP $1,265 68 payments
  4. ITI, Inc. $710 43 payments
  5. Takeda Pharmaceuticals U.S.A., Inc. $683 31 payments
  6. Otsuka America Pharmaceutical, Inc. $414 22 payments
  7. Lundbeck LLC $252 17 payments
  8. Almatica Pharma LLC $247 11 payments
  9. Bausch Health US, LLC $225 12 payments
  10. Axsome Therapeutics, Inc. $221 14 payments
  11. Other $1,128 55 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $8,838 433 payments
  2. Education $3 1 payment
Products named General payments · program years 2021–2025
  1. VRAYLAR Neuroscience $1,633 76 payments
  2. Azstarys $1,566 61 payments
  3. Adzenys XR-ODT $1,154 63 payments
  4. TRINTELLIX $683 31 payments
  5. CAPLYTA $601 39 payments
  6. VRAYLAR Neuroscience $499 24 payments
  7. REXULTI Psychiatry $372 20 payments
  8. COTEMPLA XR-ODT $316 17 payments
  9. REXULTI Psychiatry $252 17 payments
  10. APLENZIN $225 12 payments
  11. Other $2,371 119 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

434 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record